Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Influence of Rhythm and Interpersonal Relationship on Gait Parameters in Children With Autism Spectrum Disorder

1. Oktober 2026 aktualisiert von: Estrada Barranco, Universidad Europea de Madrid

Influence of Rhythm and Interpersonal Relationship on Gait Parameters in Children With Autism Spectrum Disorder: A Controlled Intervention Study

Autism Spectrum Disorder (ASD) is associated with differences in social communication, motor coordination, interpersonal synchronization, and gait. This randomized crossover study examined the influence of walking pace and social familiarity on gait parameters in 30 children aged 4-6 years with ASD. Participants completed 10-metre walking trials at three pacing conditions (100, 120, and 140 beats per minute) while walking alongside either their mother or an unfamiliar researcher. The order of the two social conditions was randomized, and all participants completed both conditions. Spatiotemporal and lower-limb kinematic gait parameters were assessed from video recordings.

Studienübersicht

Detaillierte Beschreibung

Study Design:

This randomized crossover interventional study assessed the influence of walking pace and social familiarity on gait parameters in children diagnosed with Autism Spectrum Disorder (ASD). The study included 30 children aged 4-6 years with ASD level I or II who were able to walk independently without assistive devices. Participants were recruited from Fundación AMÁS, an early intervention centre.

Participants were randomly assigned to one of two sequences. Fifteen participants completed the mother condition first, followed by the unfamiliar-researcher condition, and fifteen completed the unfamiliar-researcher condition first, followed by the mother condition. All participants therefore completed both social walking conditions. Randomization applied to the order of the social conditions.

Walking Procedure:

Participants completed walking trials under three pacing conditions: 100, 120, and 140 beats per minute. Under each pacing condition, the child walked alongside either their mother or an unfamiliar researcher, who was the same person for all participants.

The accompanying adult received the pacing cue through an earpiece, while the child received no direct auditory cue and was instructed to walk alongside the adult without holding hands. Each child completed three repetitions of a 10-metre walk in each condition.

Video recordings were obtained from a lateral view under standardized recording conditions. Only the central 2 metres of the final repetition were analysed to exclude the acceleration and deceleration phases. Gait parameters were assessed from the recordings using Kinovea® software.

Outcome Measures:

The assessed outcomes were gait speed, cadence, stride length, stride time, step time, and hip, knee, and ankle joint angles at eight predefined events and phases of the gait cycle: initial contact, loading response, mid-stance, terminal stance, pre-swing, initial swing, mid-swing, and terminal swing.

Study Population:

Eligible participants were children aged 4-6 years with a clinical diagnosis of ASD level I or II who attended regular therapy sessions at Fundación AMÁS and were able to walk independently. Children with associated syndromes or recent interventions affecting the lower limbs were excluded.

Studientyp

Interventionell

Einschreibung (Tatsächlich)

30

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

    • Madrid
      • Madrid, Madrid, Spanien, 28670
        • Universidad Europea de Madrid

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

4 Jahre bis 6 Jahre (Kind)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  • Children aged 4 to 6 years.
  • Clinical diagnosis of Autism Spectrum Disorder (ASD) (Level I or II).
  • Ability to walk independently without the use of assistive devices.
  • Parents or legal guardians provide informed consent for participation.

Exclusion Criteria:

  • Presence of other syndromes or developmental disorders.
  • History of recent surgical interventions or procedures involving the lower limbs.
  • Significant neurological or orthopedic conditions that may affect gait.
  • Any contraindications for participation in physical activities as determined by the child's healthcare provider.

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Grundlegende Wissenschaft
  • Zuteilung: Zufällig
  • Interventionsmodell: Crossover-Aufgabe
  • Maskierung: Keine (Offenes Etikett)

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Mother-first sequence

Fifteen participants first completed the walking trials alongside their mother and subsequently crossed over to complete the trials alongside the unfamiliar researcher. Participants performed the walking task under the three pacing conditions (100, 120, and 140 bpm).

Participants completed 10-metre walking trials under three pacing conditions: 100, 120, and 140 beats per minute. Under each pacing condition, participants walked alongside either their mother or an unfamiliar researcher, who was the same person for all participants. The accompanying adult received the pacing cue through an earpiece, while the child received no direct auditory cue and was instructed to walk alongside the adult without holding hands. All participants completed both social conditions, with the order of the mother and unfamiliar-researcher conditions determined by random allocation. Gait speed, cadence, stride length, stride time, step time, and hip, knee, and ankle joint angles were assessed from video recordings using Kinovea® software.

Experimental: Unfamiliar-researcher-first sequence

Fifteen participants first completed the walking trials alongside the unfamiliar researcher and subsequently crossed over to complete the trials alongside their mother. Participants performed the walking task under the three pacing conditions (100, 120, and 140 bpm).

Participants completed 10-metre walking trials under three pacing conditions: 100, 120, and 140 beats per minute. Under each pacing condition, participants walked alongside either their mother or an unfamiliar researcher, who was the same person for all participants. The accompanying adult received the pacing cue through an earpiece, while the child received no direct auditory cue and was instructed to walk alongside the adult without holding hands. All participants completed both social conditions, with the order of the mother and unfamiliar-researcher conditions determined by random allocation. Gait speed, cadence, stride length, stride time, step time, and hip, knee, and ankle joint angles were assessed from video recordings using Kinovea® software.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Cadence
Zeitfenster: During each walking condition within a single assessment session.

The number of steps taken per minute.

During each walking condition within a single assessment session.

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Step Length
Zeitfenster: During each walking condition within a single assessment session.

The distance covered in a single step, measured in meters

During each walking condition within a single assessment session.
Step Time: The duration of each step, measured in seconds
Zeitfenster: During each walking condition within a single assessment session.

The duration of each step, measured in seconds

During each walking condition within a single assessment session.
Velocity:
Zeitfenster: During each walking condition within a single assessment session.

The speed of walking, measured in meters per second.

During each walking condition within a single assessment session.
Joint Amplitudes
Zeitfenster: During each walking condition within a single assessment session.

The angles at which the hip, knee, and ankle joints move during each phase of the gait cycle, assessed in degrees

During each walking condition within a single assessment session.

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

1. Februar 2024

Primärer Abschluss (Tatsächlich)

31. Mai 2024

Studienabschluss (Tatsächlich)

31. Mai 2024

Studienanmeldedaten

Zuerst eingereicht

4. Oktober 2024

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

23. Oktober 2024

Zuerst gepostet (Tatsächlich)

26. Oktober 2024

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

6. Oktober 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

1. Oktober 2026

Zuletzt verifiziert

1. Oktober 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

NEIN

Beschreibung des IPD-Plans

Data Sensitivity: Given that the study focuses on a vulnerable population (children with Autism Spectrum Disorder), there are heightened concerns regarding the misuse or misinterpretation of the data.

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren